Home/Filings/4/0001914620-25-000012
4//SEC Filing

McGuire Annie 4

Accession 0001914620-25-000012

CIK 0001384101other

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 4:35 PM ET

Size

6.6 KB

Accession

0001914620-25-000012

Insider Transaction Report

Form 4
Period: 2025-12-16
McGuire Annie
SVP, General Counsel
Transactions
  • Sale

    Common Stock

    2025-12-16$43.13/sh10,639$458,83667,860 total
  • Sale

    Common Stock

    2025-12-16$43.68/sh100$4,36867,760 total
Footnotes (2)
  • [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025.
  • [F2]Represents weighted average sales price. Sale prices for the transactions range from $42.62 to $43.59. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

Issuer

VERACYTE, INC.

CIK 0001384101

Entity typeother

Related Parties

1
  • filerCIK 0001914620

Filing Metadata

Form type
4
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:35 PM ET
Size
6.6 KB